EFFECT OF MYC-GENE EXPRESSION ON GROWTH IN LUNG CANCER

MYC 基因表达对肺癌生长的影响

基本信息

项目摘要

The object of this project is to evaluate the role of myc-gene expression in influencing biological and biochemical characteristics of small carcinoma of the lung (SCCL). SCCL can be histopathologically categorized into at least two forms. The predominant form(s) have long been recognized as the small (oat) cell and intermediate subtypes. Another less common form is the mixed small cell/large cell morphologic type. Recently continuous cultures of SCCL have also been divided into two major forms, i.e., 1) the classic form and 2) the variant form. These two types have different biochemical and biological characteristics and have been correlated with the small cell/intermediate cell and small cell/large cell histopathologic forms in patients respectively. Of particular interest has been the observation that practically all the variant cell lines have significant amplification of the c-myc or the related n-myc genes while this rarely occurs in the classic cell lines. The specific aims of this investigation will be to: 1) cotransfect SCCL cells which are not expressing the c-myc gene with cloned v-myc or c-myc sequences and vector-Ecogpt DNA using the calcium phosphate transfection method; 2) select cells containing the transfected genes with the mycophenolic acid selection method; 3) clone the transfected cells and determine the relative expression of the myc gene in these transfected clones by Southern and Northern blotting of DNA and RNA respectively and hybridization with a c-myc probe; and 4) compare the populations of cells containing the transfected activated myc-gene for: (a) proliferative capacity; (b) colony forming capability; (c) tumorigenicity in nude mice; and (d) hormone as well as L-DOPA decarboxylase production with the original cell line which did not express the myc-gene. These investigations will lead to a much better understanding of the role of c-myc expression in SCCL and whether or not it is significantly related to important biological and functional characteristics of this tumor. (X)
该项目的目的是评估Myc-Gene表达的作用 在影响小的生物学和生化特征方面 肺癌(SCCL)。 SCCL可以在组织病理学上分类 至少两种形式。 长期以来一直认识到主要形式 作为小(燕麦)细胞和中间亚型。 另一个不太常见 形式是混合的小细胞/大细胞形态类型。 最近 SCCL的连续培养也已分为两种主要形式: 即1)经典形式和2)变体形式。 这两种类型有 不同的生化和生物学特征 与小细胞/中间细胞和小细胞/大细胞相关 患者的组织病理学形式分别。 特别感兴趣的 一直以来,几乎所有变体细胞系都有 C-MYC或相关N-MYC基因的显着扩增,而 这很少发生在经典细胞系中。 这项调查的具体目的是:1)共转化SCCL 未用克隆的V-MYC或C-MYC表达C-MYC基因的细胞 使用磷酸钙转染序列和载体-Ecogpt DNA 方法; 2)选择包含带有转染基因的细胞 霉酚酸选择方法; 3)克隆转染的细胞和 确定在这些转染中MYC基因的相对表达 DNA和RNA的南部和北部印迹的克隆以及 与C-MYC探针杂交; 4)比较细胞的种群 包含转染的激活的myc-gene:(a)增殖 容量; (b)菌落形成能力; (c)裸鼠的致瘤性; (d)激素以及L-DOPA脱羧酶的产生 原始细胞系未表达Myc-Gene。 这些调查将导致对角色的更好理解 SCCL中C-MYC表达的表达以及它是否显着相关 对于该肿瘤的重要生物学和功能特征。 (x)

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

GEORGE D. SORENSON的其他基金

PLASMA DNA IN PULMONARY AND PANCREATIC CARCINOMA
肺癌和胰腺癌中的血浆 DNA
  • 批准号:
    2099298
    2099298
  • 财政年份:
    1994
  • 资助金额:
    $ 12.42万
    $ 12.42万
  • 项目类别:
PLASMA DNA IN PULMONARY AND PANCREATIC CARCINOMA
肺癌和胰腺癌中的血浆 DNA
  • 批准号:
    2099301
    2099301
  • 财政年份:
    1994
  • 资助金额:
    $ 12.42万
    $ 12.42万
  • 项目类别:
PLASMA DNA IN PULMONARY AND PANCREATIC CARCINOMA
肺癌和胰腺癌中的血浆 DNA
  • 批准号:
    2099300
    2099300
  • 财政年份:
    1994
  • 资助金额:
    $ 12.42万
    $ 12.42万
  • 项目类别:
MOLECULAR GENETIC STUDIES OF METASTASIS IN LUNG CANCER
肺癌转移的分子遗传学研究
  • 批准号:
    3190780
    3190780
  • 财政年份:
    1989
  • 资助金额:
    $ 12.42万
    $ 12.42万
  • 项目类别:
MOLECULAR GENETIC STUDIES OF METASTASIS IN LUNG CANCER
肺癌转移的分子遗传学研究
  • 批准号:
    3190781
    3190781
  • 财政年份:
    1989
  • 资助金额:
    $ 12.42万
    $ 12.42万
  • 项目类别:
MOLECULAR GENETIC STUDIES OF METASTASIS IN LUNG CANCER
肺癌转移的分子遗传学研究
  • 批准号:
    3190778
    3190778
  • 财政年份:
    1989
  • 资助金额:
    $ 12.42万
    $ 12.42万
  • 项目类别:
EFFECT OF MYC-GENE EXPRESSION ON GROWTH IN LUNG CANCER
MYC 基因表达对肺癌生长的影响
  • 批准号:
    3180746
    3180746
  • 财政年份:
    1985
  • 资助金额:
    $ 12.42万
    $ 12.42万
  • 项目类别:
EFFECT OF MYC-GENE EXPRESSION ON GROWTH IN LUNG CANCER
MYC 基因表达对肺癌生长的影响
  • 批准号:
    3180744
    3180744
  • 财政年份:
    1985
  • 资助金额:
    $ 12.42万
    $ 12.42万
  • 项目类别:
CALCITONIN IN THYROID CARCINOMA
甲状腺癌中的降钙素
  • 批准号:
    3171150
    3171150
  • 财政年份:
    1983
  • 资助金额:
    $ 12.42万
    $ 12.42万
  • 项目类别:
SECRETION AND PROLIFERATION IN SMALL CELL CARCINOMA
小细胞癌的分泌和增殖
  • 批准号:
    3171630
    3171630
  • 财政年份:
    1983
  • 资助金额:
    $ 12.42万
    $ 12.42万
  • 项目类别:

相似国自然基金

红景天甙生物合成依赖的酪氨酸代谢支路途径研究
  • 批准号:
    81660628
  • 批准年份:
    2016
  • 资助金额:
    37.0 万元
  • 项目类别:
    地区科学基金项目
海洋萎缩芽孢杆菌Bacillamide C生物合成机制研究
  • 批准号:
    31300104
  • 批准年份:
    2013
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

EFFECT OF MYC-GENE EXPRESSION ON GROWTH IN LUNG CANCER
MYC 基因表达对肺癌生长的影响
  • 批准号:
    3180746
    3180746
  • 财政年份:
    1985
  • 资助金额:
    $ 12.42万
    $ 12.42万
  • 项目类别:
EFFECT OF MYC-GENE EXPRESSION ON GROWTH IN LUNG CANCER
MYC 基因表达对肺癌生长的影响
  • 批准号:
    3180744
    3180744
  • 财政年份:
    1985
  • 资助金额:
    $ 12.42万
    $ 12.42万
  • 项目类别:
NEUROENDOCRINE DIFFERENTIATION IN HUMAN TUMORS
人类肿瘤的神经内分泌分化
  • 批准号:
    3164938
    3164938
  • 财政年份:
    1978
  • 资助金额:
    $ 12.42万
    $ 12.42万
  • 项目类别:
NEUROENDOCRINE DIFFERENTIATION IN HUMAN TUMORS
人类肿瘤的神经内分泌分化
  • 批准号:
    3164939
    3164939
  • 财政年份:
    1978
  • 资助金额:
    $ 12.42万
    $ 12.42万
  • 项目类别:
DOPA-DECARBOXYLASE IN SECRETORY CAPACITY OF THYROID CARCINOMA
多巴脱羧酶在甲状腺癌分泌能力中的作用
  • 批准号:
    4697952
    4697952
  • 财政年份:
  • 资助金额:
    $ 12.42万
    $ 12.42万
  • 项目类别: